Current Issue

Sponsored
Keywords

Geron - Related Content

New Life for Embryonic Stem Cells
February 1, 2013
Positive results from new studies show that ESCs still hold much potential for regenerative medicine.
This Month Last Year: Shire and Thermo Fisher’s Acquisitions and Geron’s hESC Plans
May 1, 2012
While Geron’s good news in May 2011 didn’t last long, Shire and Thermo hope their moves strengthen their businesses.
Where Does Geron’s Exit from Embryonic Stem Cells Leave the Field?
November 28, 2011
Given that the firm with the most money has just quit, questions about how to succeed are rampant.
What Comes After Dendreon’s Provenge?
October 18, 2010
Success of prostate cancer vaccine has ushered in a wave of autologous vaccine development.
Geron’s Setback with Testing Its hESC Therapy in Humans Points to FDA’s Continued Cautionary Stance
August 28, 2009
Data from animal studies prompted the clinical hold, which highlights the various kinks yet to be worked out.

STEM CELL THERAPIES ON THE RISE
- Linda Powers, Cofounder and Managing Director of Toucan Capital, is interviewed by GEN's Editor in Chief, John Sterling